Company Filing History:
Years Active: 2008-2012
Title: The Innovations of Andrew Mark Vick
Introduction
Andrew Mark Vick is a notable inventor based in Fishers, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compounds. With a total of 4 patents to his name, Vick's work focuses on improving treatments for various medical conditions.
Latest Patents
Vick's latest patents include innovative solutions such as GLP-1 analog fusion proteins. This invention provides specific GLP-1 analogs fused to specific IgG4-Fc derivatives. These fusion proteins have an increased half-life, decreased immunogenicity, and reduced effector activity. They are particularly useful in treating diabetes, obesity, irritable bowel syndrome, and other conditions that benefit from lowering plasma glucose, inhibiting gastric and/or intestinal motility, and reducing food intake. Another significant patent is for GLP-1 pegylated compounds. This invention involves GLP-1 compounds coupled to two polyethylene glycol molecules or derivatives, resulting in a biologically active peptide with an extended half-life and slower clearance compared to unPEGylated peptides. These PEGylated GLP-1 compounds are beneficial in treating conditions that require lowering blood glucose, decreasing food intake, and increasing beta cell population.
Career Highlights
Andrew Mark Vick is currently employed at Eli Lilly and Company, where he continues to innovate in the field of pharmaceuticals. His work has had a profound impact on the development of new treatments that improve patient outcomes.
Collaborations
Vick has collaborated with notable colleagues such as Wolfgang Glaesner and Rohn Lee Millican, Jr. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Andrew Mark Vick's contributions to biotechnology through his patents and work at Eli Lilly and Company highlight his role as an influential inventor. His innovations in GLP-1 compounds are paving the way for improved treatments for various health conditions.